S. Erba
University of Milan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. Erba.
Investigative Ophthalmology & Visual Science | 2018
Alessandro Invernizzi; Eleonora Benatti; Mariano Cozzi; S. Erba; Shiva Vaishnavi; Kiran Kumar Vupparaboina; Giovanni Staurenghi; Jay Chhablani; Mark C. Gillies; Francesco Viola
Purpose To correlate changes in choroidal thickness and vascularity index with disease activity in patients with neovascular age-related macular degeneration (nAMD). Methods Eyes diagnosed with AMD that had two sequential visits within 12 months and that had no choroidal neovascularization (CNV) or had inactive CNV at the first visit were included. Those that had active CNV at follow-up were enrolled as cases. Eyes that did not developed a CNV or that were still inactive at the second visit were enrolled as controls. Disease activity was based on optical coherence tomography (OCT) and fluorescein angiography findings. Subfoveal choroidal thickness (SCT), mean choroidal thickness (MCT), and choroidal vascularity index (CVI) were assessed on enhanced depth imaging OCT and compared between the baseline and follow-up visit. Subgroup analysis accounting for lesion type and previous treatment, if any, were performed. Results Sixty-five eyes from 60 patients (35 females) and 50 age- and sex-matched controls were included. At the active visit, cases had an increase from 164 ± 67 μm to 175 ± 70 μm in mean ± SD SCT and from 144 ± 45 μm to 152 ± 45 μm in MCT (both P < 0.0001). The mean CVI also increased at from 54.5% ± 3.3% to 55.4% ± 3.8% (P = 0.04). Controls did not show significant changes in choroidal measurements between the two visits. Mean SCT, MCT, and CVI values were similar for previously treated and treatment-naive eyes. Conclusions Choroidal thickness and CVI significantly increased with active disease in nAMD eyes. Changes in choroidal thickness may predict CNV development or recurrence before they are otherwise evident clinically.
American Journal of Ophthalmology | 2018
Federico Corvi; Marco Pellegrini; S. Erba; Mariano Cozzi; Giovanni Staurenghi; Andrea Giani
Ophthalmology Retina | 2018
Alessandro Invernizzi; Marco Pellegrini; Alessandra Acquistapace; Eleonora Benatti; S. Erba; Mariano Cozzi; Mario Cigada; Francesco Viola; Mark C. Gillies; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2017
Alessandra Acquistapace; Alessandro Invernizzi; Marco Pellegrini; Eleonora Benatti; S. Erba; Mariano Cozzi; Mario Cigada; Francesco Viola; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2017
S. Erba; Alba Xhepa; Alessandro Invernizzi; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2016
S. Erba; Giulia Delledonne; Carlo Bianchi; Mariano Cozzi; Alessandro Babbi; Mario Cigada; Ferdinando Bottoni; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2016
Mariano Cozzi; S. Erba; Alessandro Invernizzi; Marco Pellegrini; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2016
Chiara Preziosa; Isabella D'Agostino; Ugo Nava; S. Erba; Matteo G. Cereda; Ferdinando Bottoni; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2015
S. Erba; Sara Bochicchio; Mariano Cozzi; Carlo Bianchi; Matteo G. Cereda; Giovanni Staurenghi
Investigative Ophthalmology & Visual Science | 2012
S. Erba; Antonio Caimi; Claudia Orini; Paola Salvetti; Andrea Giani; Giovanni Staurenghi